Roche agreed to acquire PathAI, according to source material published on October 16, 2026. The reported purchase consideration is $1,050,000,000. This summary is limited to the approved transaction facts in the cited source evidence.
Roche agreed to acquire PathAI
Roche agreed to acquire PathAI
AcquisitionUSD1,050,000,000Technology, Information and MediaUS
Get the full PathAI company profile
Access contacts, investors, buying signals & more
Acquired
PathAI
United StatesTechnology, Information and Media
Deal value
USD1,050,000,000
October 16, 2026
Acquirer
Roche
Biotechnology Research
Unlock GTM signals
Discover PathAI's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at PathAI.